Monday, November 16, 2026 Vol. I · No. 4
Health · Via STAT

STAT+: FDA approves new breast cancer drug, providing new option for some patients, boost for Roche

Image: STAT

The FDA approved a new breast cancer drug from Roche, teeing up the launch of a medicine the company has said could become its top-selling product ever.

This is a brief. The reporting belongs to STAT — read the complete story, with full context and credits, at the source.

Read the full story at STAT ↗

statnews.com

More from the Health desk